{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:04:16Z","timestamp":1789761856357,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urolonc.2026.04.001","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:11:09Z","timestamp":1789758669000},"page":"847-856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["FOCS-24: An integrated oncologic\u2013functional endpoint and its preoperative nomogram after focal therapy for localized prostate cancer"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-4132","authenticated-orcid":false,"given":"Umberto","family":"Anceschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Misuraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco Simone","family":"Flammia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariaconsiglia","family":"Ferriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Maria","family":"Bove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Bologna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Capecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie Claire","family":"Licari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Iori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Capecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Leonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Lugnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.04.001_bib0001","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41391-022-00501-0","article-title":"Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes","volume":"26","author":"Heard","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2025.02.003","article-title":"Outcomes of Focal therapy for localized prostate cancer: a systematic review and meta-analysis of prospective studies","author":"\u015alusarczyk","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0003","doi-asserted-by":"crossref","first-page":"712.e1","DOI":"10.1016\/j.clgc.2023.04.013","article-title":"An update on focal therapy for prostate cancer","volume":"21","author":"Ayerra Perez","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0004","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41391-023-00698-8","article-title":"Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)","volume":"27","author":"Nicoletti","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","article-title":"An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years?","volume":"81","author":"Hopstaken","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0006","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41443-020-00357-9","article-title":"Erectile function after focal therapy for localized prostate cancer: a systematic review","volume":"33","author":"Fallara","year":"2021","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0007","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/iju.14991","article-title":"Focal therapy of localized prostate cancer","volume":"29","author":"Fujihara","year":"2022","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0008","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.eururo.2023.06.013","article-title":"Primary whole-gland ablation for the treatment of clinically localized prostate cancer: a Focal Therapy Society Best Practice statement","volume":"84","author":"Deivasigamani","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0009","doi-asserted-by":"crossref","first-page":"194.e9","DOI":"10.1016\/j.urolonc.2024.11.009","article-title":"Prostate ablation for the management of localized prostate cancer","volume":"43","author":"Sidana","year":"2025","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bju.16122","article-title":"Prostate cancer outcomes following whole-gland and focal high-intensity focused ultrasound","volume":"132","author":"Parry","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0011","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/bju.16213","article-title":"Focal therapy with high-intensity focused ultrasound for prostate cancer: 3-year outcomes from a prospective trial","volume":"133","author":"Kaufmann","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0012","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.euf.2023.04.008","article-title":"A novel nomogram to identify candidates for focal therapy among patients with localized prostate cancer diagnosed via Magnetic resonance imaging-targeted and systematic biopsies: a European multicenter study","volume":"9","author":"Mjaess","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0013","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.euf.2023.06.015","article-title":"Re: Mjaess G., Peltier A., Roche J.B., et al. A novel nomogram to identify candidates for focal therapy among patients with localized prostate cancer diagnosed via MRI-targeted and systematic biopsies: a European multicenter study","volume":"10","author":"Gravina","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0014","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euf.2023.07.005","volume":"10","author":"Mjaess","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-020-00928-w","article-title":"A scoping review of core outcome sets and their \u2018mapping\u2019 onto real-world data using prostate cancer as a case study","volume":"20","author":"Meregaglia","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.euo.2021.10.004","article-title":"Standardising the assessment of patient-reported outcome measures in localised prostate cancer. A systematic review","volume":"5","author":"Ratti","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0017","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/luts.12415","article-title":"How international is the International Prostate Symptom Score? A literature review of validated translations of the IPSS, the most widely used self-administered patient questionnaire for male lower urinary tract symptoms","volume":"14","author":"Yao","year":"2022","journal-title":"Low Urin Tract Symptoms"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0018","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/19317611.2021.1936333","article-title":"Post-radical prostatectomy erectile dysfunction assessed using the IIEF-5 questionnaire - a systematic literature review","volume":"34","author":"Jurys","year":"2021","journal-title":"Int J Sex Health"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0019","article-title":"Head to Head impact of margin, ischemia, complications, score versus a novel trifecta score on oncologic and functional outcomes after robotic-assisted partial nephrectomy: results of a multicenter series","author":"Anceschi","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0020","doi-asserted-by":"crossref","DOI":"10.23736\/S0393-2249.20.03813-8","article-title":"Comprehensive long-term assessment of outcomes following robot-assisted partial nephrectomy for renal cell carcinoma: the ROMe\u2019s achievement and its predicting nomogram","author":"Brassetti","year":"2020","journal-title":"Minerva Urol e Nefrol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/M22-0844","article-title":"Assessing performance and clinical usefulness in prediction models with survival outcomes: practical guidance for Cox proportional hazards models","volume":"176","author":"McLernon","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0022","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jval.2025.01.005","article-title":"A comparison of the performance of 6 surrogacy models, including weighted linear regression, meta-regression, and bivariate meta-analysis","volume":"28","author":"Vickers","year":"2025","journal-title":"Value Heal"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0023","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.eururo.2014.09.018","article-title":"Focal therapy: patients, interventions, and outcomes - a report from a consensus meeting","volume":"67","author":"Donaldson","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0024","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41391-020-0206-6","article-title":"Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI","volume":"23","author":"Connor","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrurol.2016.177","article-title":"An update on focal therapy for prostate cancer","volume":"13","author":"Perera","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.21037\/atm-21-5033","article-title":"Focal cryotherapy for prostate cancer: a contemporary literature review","volume":"11","author":"Kotamarti","year":"2023","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0027","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/s1677-5538.ibju.2021.0091","article-title":"Available evidence on HIFU for focal treatment of prostate cancer: a systematic review","volume":"48","author":"Bakavicius","year":"2022","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002447","article-title":"Core outcome set-STAndards for development: the COS-STAD recommendations","volume":"14","author":"Kirkham","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0029","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ucl.2021.07.011","article-title":"Evolution of focal therapy in prostate cancer: past, present, and future","volume":"49","author":"Arcot","year":"2022","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MOU.0000000000000838","article-title":"Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years","volume":"31","author":"Kayano","year":"2021","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urolonc.2026.04.001_bib0031","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00345-017-2130-5","article-title":"PSA kinetics following primary focal cryotherapy (hemiablation) in organ-confined prostate cancer patients","volume":"36","author":"Kongnyuy","year":"2018","journal-title":"World J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926002000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926002000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:12:06Z","timestamp":1789758726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926002000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1078143926002000"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.04.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOCS-24: An integrated oncologic\u2013functional endpoint and its preoperative nomogram after focal therapy for localized prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}